Aditum Bio is a biotech venture capital firm focused on translating scientific discoveries into innovative medicines for underserved patient populations. Launched in 2019 by industry veterans Joe Jimenez and Dr. Mark Fishman, Aditum Bio's agile model rapidly forms companies and assembles expert teams to develop clinic-ready therapies. With a unique approach combining scientific expertise and operational capabilities, Aditum aims to provide patients access to medicines that may otherwise be overlooked.
Aditum Bio is seeking a Vice President of Clinical Development to own the overall design and execution of portfolio company clinical trials. This role requires a strong command of early clinical phase drug development, experience with highly matrixed cross-functional teams, and expertise in regulatory and compliance. The ideal candidate will translate preclinical data into clinical trial design and ensure patient safety.
Aditum Bio is a biotech venture capital firm focused on translating scientific discoveries into innovative medicines for underserved patient populations. Launched in 2019 by industry veterans Joe Jimenez and Dr. Mark Fishman, Aditum Bio's agile model rapidly forms companies and assembles expert teams to develop clinic-ready therapies. With a unique approach combining scientific expertise and operational capabilities, Aditum aims to provide patients access to medicines that may otherwise be overlooked.
Precision For Medicine